In one paragraphArticle in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Ibtihal SegmaniLaboratory of Integrated Cancer Research, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca 21100, Morocco.
Chiara D'AprileExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0000-0002-3380-043X Laura CherchiExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0009-0007-1050-9299 Eleonora PozziExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0000-0001-6438-286X Alessia ChiorazziExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0000-0002-3469-1829 Annalisa CantaExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0000-0003-4946-647X Paola AlbertiExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0000-0001-6106-6183 Cristina MeregalliExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0000-0002-4281-4577 Lisa FantoniExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.
Elisa BallariniExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0000-0002-1678-6357 Virginia Rodriguez MenendezExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.
Elisabetta DonzelliExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0000-0002-9495-4256 Silvia FermiExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0009-0007-2387-1035 Arianna ScuteriExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0000-0003-0240-313X Houda FilaliLaboratory of Integrated Cancer Research, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca 21100, Morocco.
Guido CavalettiExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0000-0003-4128-2406 Valentina Alda CarozziExperimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monz, Italy.ORCID 0000-0003-0963-7107 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a dose-limiting complication of paclitaxel (PTX) therapy, for which effective treatments are still lacking. This study evaluated the neuroprotective potential of Thymoquinone (TQ), a bioactive derivative of
Indexed as
BenzoquinonesNeuroprotective AgentsPaclitaxelPainPeripheral Nervous System DiseasesAnimalsAntineoplastic Agents, PhytogenicFemaleGanglia, SpinalHumansMCF-7 CellsMDA-MB-231 CellsRatsRats, Sprague-DawleySirtuin 1Antineoplastic Agents, PhytogenicBenzoquinonesNeuroprotective AgentsPaclitaxelSirtuin 1thymoquinonein vivo/in vitro modelspaclitaxelperipheral neuropathySIRT1 expressionThymoquinone
Identifiers
PMID42793114
PMCPMC13604513
What OpenQuestion holds
Textmetadata
Read underepoch 390